Pfizer Comirnaty COVID-19 vaccine information

This page contains documents relating specifically to the Pfizer Comirnaty® vaccine.

National protocol for Comirnaty® COVID-19 mRNA vaccine

National protocol for Comirnaty® 10 microgram/dose COVID-19 mRNA vaccine

 

Pfizer BioNTech COVID-19 vaccine information

Gov.uk - Regulatory approval of COVID-19 Pfizer BioNTech vaccine	Regulatory approval of COVID-19 Pfizer BioNTech vaccine
Comirnaty® vaccine Patient Information Leaflet	COVID-19: vaccine Comirnaty® Patient Information Leaflet COVID-19: vaccine Comirnaty® (10micrograms/dose) concentrate Patient Information Leaflet Children 5 to 11
Comirnaty® vaccine SPC	COVID-19: vaccine Comirnaty® 'SPC' COVID-19: vaccine Comirnaty® (10micrograms/dose) concentrate 'SPC' Children 5 to 11

 

SPS Pfizer-BioNTech information

Information specific to Pfizer vaccine

Managing risks associated with the introduction of the Comirnaty vaccine for children 5 to 11 years old